Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Damora Therapeutics, Inc.

NASDAQ: DMRA · Life Sciences · 2 alerts · CIK 1800315

Share price
$22.50Close, Nov 16
Market cap
$1.39B
Shares outstanding
61.9MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Damora Therapeutics, Inc. filings on SEC EDGAR ↗

7:01 AM ET Form 4
Insider Buying

Damora Therapeutics Director, President and CEO Jennifer Jarrett Buys $253K of Stock

Jennifer Jarrett, Director, President and CEO, bought 12,500 shares of Damora Therapeutics, Inc. at $20.23 a share, worth $253K in total on Sep 25, 2026. Shares held after the trade: 512,500 (+2.5%).

Value
$253K
Shares
12,500
Price
$20.23
Role
Director, President and CEO
Holding change
+2.5%
Trade date
Sep 25, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.